Case #501
Hx:

A 68-year-old woman with history of diabetes mellitus, peripheral arterial disease, and breast cancer is referred to your outpatient clinic for decision regarding antithrombotic agents. In laboratory findings, creatinine and platelet count were 0.9 mg/dL and 88,000 × 109/L, respectively.

 

She was receiving Aspirin 80 mg daily, Rivaroxaban 2.5 mg BD, Pantoprazole 40 mg daily, Atorvastatin 40 mg BD, and Empagliflozin/Linagliptin 10/5 mg daily. Her chemotherapy regimen was Docetaxel + Carboplatin + Trastuzumab.


Q:

Which is your preferred antithrombotic regimen?


Opt:
To view the educational contents and comments, please submit your answer! Your answer is not saved.